DEUTETRABENAZINE: UPDATE ON FIRST TIME USE OF SD-809 IN HUNTINGTON'S DISEASE (FIRST-HD) AND ALTERNATIVE FOR REDUCING CHOREA IN HUNTINGTON'S DISEASE (ARC-HD)

被引：0
|
作者：
Testa, Claudia [1 ]
机构：
[1] Huntington Study Grp, Rochester, NY USA
来源：
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY | 2016年 / 87卷
关键词：
D O I：
10.1136/jnnp-2016-314597.286
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
M1
引用
收藏
页码：A101 / A101
页数：1
相关论文
共 39 条
  • [1] First time use of SD-809 in Huntington's disease (first-HD)
    Frank, S.
    MOVEMENT DISORDERS, 2015, 30 : S531 - S532
  • [2] First time use of SD-809 in Huntington Disease (first-HD)
    Frank, Samuel A.
    NEUROLOGY, 2015, 85 (04) : E47 - E47
  • [3] First Time Use of SD-809 in Huntington Disease (FirstHD) and Alternative for Reducing Chorea in Huntington Disease (ARC-HD): Results from the Switch Cohort.
    Testa, Claudia
    NEUROTHERAPEUTICS, 2016, 13 (01) : 242 - 242
  • [4] Alternative for reducing chorea in Huntington's disease (ARC-HD): Results from the Switch cohort
    Frank, S.
    MOVEMENT DISORDERS, 2015, 30 : S531 - S531
  • [5] Deutetrabenazine Effect on Total Motor Score in Patients with Huntington Disease (First-HD)
    Frank, Samuel
    Stamler, David
    Sung, Victor
    Claassen, Daniel
    Janicki, Sarah
    Loy, Clement
    Furr-Stimming, Erin
    Oakes, David
    Testa, Claudia
    NEUROLOGY, 2016, 86
  • [6] Safety and Efficacy of Deutetrabenazine at High versus Lower Daily Dosages in the ARC-HD Study to Treat Chorea in Huntington Disease
    Frank, Samuel
    Testa, Claudia M.
    Goldstein, Jody
    Kayson, Elise
    Leavitt, Blair R.
    Oakes, David
    O'Neill, Christine
    Whaley, Jacquelyn
    Gross, Nicholas
    Chaijale, Nayla
    Barash, Steve
    Gordon, Mark Forrest
    CNS DRUGS, 2025, 39 (02) : 185 - 195
  • [7] Long-Term Efficacy and Safety of Deutetrabenazine for Chorea in Huntington's Disease: Results From the ARC-HD Open-Label Study
    Frank, Samuel
    Testa, Claudia M.
    Stamler, David
    Kayson, Elise
    Oakes, David
    Vaughan, Christina
    Goldstein, Jody
    Whaley, Jacquelyn
    Davis, Matthew D.
    Gordon, Mark Forrest
    Savolay, Juha-Matti
    NEUROTHERAPEUTICS, 2020, 17 (SUPPL 1) : 27 - 28
  • [8] Tetrabenazine Use in Patients With Huntington's Disease (HD) Chorea
    Sung, Victor W.
    Iyer, Ravi
    Schilling, Traci
    Buzinec, Paul N.
    NEUROLOGY, 2017, 88
  • [9] Evaluation of quality of life (QOL), patient- and clinician-reported outcomes with deutetrabenazine treatment of chorea in Huntington disease in first-HD
    Testa, C. M.
    Claassen, D. O.
    Oakes, D.
    Stamler, D.
    Sung, V.
    Frank, S.
    MOVEMENT DISORDERS, 2016, 31 : S369 - S369
  • [10] Evaluating swallowing function in patients with Huntington disease enrolled in the first-HD study
    Frank, S. A.
    Claassen, D. O.
    Janicki, S.
    Oakes, D.
    Stamler, D.
    Sung, V.
    Vaughn, C.
    Testa, C. M.
    MOVEMENT DISORDERS, 2016, 31 : S370 - S370
1234